TimeSmartAI, a Kitchener, Ontario–based AI-driven platform for physician contract compliance and compensation management, has secured a strategic investment. 

Investors 

Led by Graphite Ventures, with participation from MaRS Investment Accelerator Fund, Velocity Fund, Archangel Network of Funds, and a group of strategic angel investors. 

Graphite Ventures is a Toronto-based early-stage venture capital firm focused on backing Canadian technology startups, particularly in B2B sectors at the Pre-Seed, Seed, and Series A stages. The firm targets industries such as B2B SaaS, fintech, digital health, proptech, and enterprise software. 

TimeSmartAI Use of Funds 

The company will use the funding to expand engineering and technical teams, accelerate product innovation, enhance AI capabilities, and scale customer success, sales, and support operations. 

About TimeSmartAI 

Led by CEO Ismail Moola, TimeSmartAI is a healthcare technology company that provides a clinician-led solution designed to help healthcare organizations improve contract compliance, streamline operational efficiency, and automate physician payment processes. Its platform centralizes contract management, time tracking, payment validation, and audit readiness into a unified system tailored for large healthcare environments. TimeSmartAI integrates seamlessly with various healthcare management systems, electronic health records (EHRs), and other essential tools. 

Funding Details 

Company: TimeSmartAI Inc. 

Raised: Undisclosed 

Round: Strategic 

Funding Date: April 2026 

Lead Investor: Graphite Ventures 

Additional Investors: MaRS Investment Accelerator Fund, Velocity Fund, Archangel Network of Funds 

Company Website: https://timesmart.ai/  

Software Category: Healthcare AI / Contract Compliance & Compensation Management 

Source: https://www.businesswire.com/news/home/20260331252513/en/